Heidelberg Pharma AG (HPHA) - Cash Flow Conversion Efficiency

Latest as of May 2025: -0.299x

Based on the latest financial reports, Heidelberg Pharma AG (HPHA) has a cash flow conversion efficiency ratio of -0.299x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.53 Million ≈ $-6.46 Million USD) by net assets (€18.52 Million ≈ $21.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Heidelberg Pharma AG fund operations to measure how many days the company can operate on defensive assets alone.

Heidelberg Pharma AG - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Heidelberg Pharma AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Heidelberg Pharma AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heidelberg Pharma AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Maple Gold Mines Ltd V:MGM	-0.353x
K2 Capital Acquisition Corporation NASDAQ:KTWO	-0.003x
Ekter SA AT:EKTER	0.073x
LAUNCH TECH CO. H YC-01 F:LAN	N/A
Suryamas Dutamakmur Tbk JK:SMDM	-0.014x
Mondi Turkey Oluklui Mukavva Kagit ve Ambalaj Sanayi A.S. IS:MNDTR	N/A
Caisse Regionale de Credit Agricole Mutuel Loire HauteLoire PA:CRLO	0.036x
Adisyn Ltd AU:AI1	-0.042x

Annual Cash Flow Conversion Efficiency for Heidelberg Pharma AG (2016–2024)

The table below shows the annual cash flow conversion efficiency of Heidelberg Pharma AG from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see HPHA market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-11-30	€30.87 Million ≈ $36.09 Million	€-29.59 Million ≈ $-34.59 Million	-0.959x	-40.46%
2023-11-30	€49.34 Million ≈ $57.68 Million	€-33.67 Million ≈ $-39.37 Million	-0.682x	-413.10%
2022-11-30	€66.64 Million ≈ $77.91 Million	€-8.86 Million ≈ $-10.36 Million	-0.133x	+96.65%
2021-11-30	€6.70 Million ≈ $7.83 Million	€-26.61 Million ≈ $-31.11 Million	-3.973x	-185.96%
2020-11-30	€12.88 Million ≈ $15.06 Million	€-17.89 Million ≈ $-20.92 Million	-1.389x	-164.54%
2019-11-30	€16.29 Million ≈ $19.05 Million	€-8.56 Million ≈ $-10.00 Million	-0.525x	-36.17%
2018-11-30	€25.89 Million ≈ $30.26 Million	€-9.98 Million ≈ $-11.67 Million	-0.386x	-79.83%
2017-11-30	€37.02 Million ≈ $43.28 Million	€-7.94 Million ≈ $-9.28 Million	-0.214x	+67.98%
2016-11-30	€9.76 Million ≈ $11.41 Million	€-6.53 Million ≈ $-7.64 Million	-0.670x	--

About Heidelberg Pharma AG

F:HPHA Germany Biotechnology

Market Cap

$141.66 Million

€121.17 Million EUR

Market Cap Rank

#17990 Global

#1678 in Germany

Share Price

€2.59

Change (1 day)

+2.37%

52-Week Range

€2.31 - €4.79

All Time High

€8.94